For: | Sun YQ, Wu Y, Li MR, Wei YY, Guo M, Zhang ZL. Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function. World J Gastroenterol 2024; 30(43): 4660-4668 [PMID: 39575408 DOI: 10.3748/wjg.v30.i43.4660] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i43/4660.htm |
Number | Citing Articles |
1 |
Samira Farhadi, Saeed Mohammadi, Abdulaziz Y AlKindi, Issa S Al-Amri. Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction. World Journal of Biological Chemistry 2025; 16(1): 104535 doi: 10.4331/wjbc.v16.i1.104535
|
2 |
Zhiwen Fu, Jiafeng Zhou, Hongye Pan, Song Yang, Zhenzhen Pan, Yujia Shen, Jianbiao Yao, Jiangning Hu. QingGan LiDan capsules improved alcoholic liver injury by regulating liver lipid transport and oxidative stress in mice. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1575280
|